Showing results (141-150 of 165) with videos related to
Sort By:
Pageof 17
The New England Journal of Medicine|October 17, 2025
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i>-Mutated Advanced NSCLCPasi A Jänne, David Planchard, Kunihiko Kobayashi, et al.Future Oncology (London, England)|July 25, 2019
ASTRIS: a global real-world study of osimertinib in >3000 patients with <i>EGFR</i> T790M positive non-small-cell lung cancerFilippo de Marinis, Yi-Long Wu, Gilberto de Castro, et al.Nature Communications|May 26, 2018
Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patientsCheng Wang, Rong Yin, Juncheng Dai, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 22, 2023
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRAS<sup>G12C</sup> in Patients With NSCLC: Phase 1 Study ResultsZiming Li, Zhengbo Song, Yanqiu Zhao, et al.National Science Review|August 15, 2022
Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasisYujuan Jin, Qiqi Zhao, Weikang Zhu, et al.National Science Review|December 29, 2023
Correction to: Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasisYujuan Jin, Qiqi Zhao, Weikang Zhu, et al.Cell Stem Cell|April 9, 2024
Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancerShenyi Yin, Ying Yu, Nan Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2023
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung CancerPasi A Jänne, David Planchard, Kunihiko Kobayashi, et al.Cancer Discovery|April 11, 2022
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion MutationsMengzhao Wang, James Chih-Hsin Yang, Paul L Mitchell, et al.Therapeutic Advances in Medical Oncology|November 7, 2022
Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring <i>MET</i> exon 14 skipping alterations: a <i>post hoc</i> analysis of a pivotal phase 2 studyYongfeng Yu, Yongxin Ren, Jian Fang, et al.Pageof 17